Key Insights The considerable ownership by retail investors in XOMA Royalty indicates that they collectively have ...

O n Monday, H.C. Wainwright maintained a Buy rating on XOMA Ltd . (NASDAQ: NASDAQ:XOMA) but reduced the price target for the company's shares from $123.00 to $104.00. Currently trading at $26.61 ...

XOMA Royalty Corp (NASDAQ:XOMA), a $313 million market cap company, experienced a significant stock sale as reported in a recent SEC filing. Several major investors, including BVF Partners L.P ...

XOMA (NASDAQ:XOMA – Get Free Report) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Tuesday. Separately, HC Wainwright dropped their ...

As of 1:16:30 PM EST. Market Open. EMERYVILLE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its ...

XOMA’s presentations can also be accessed by visiting the investor relations section of the Company’s website at www.xoma.com.. A replay of each presentation will be available and archived on ...

EMERYVILLE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Analysts' ratings for XOMA Royalty (NASDAQ:XOMA) over the last quarter vary from bullish to bearish, as provided by 5 analysts. Summarizing their recent assessments, the table below illustrates ...